S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0085 SEK Market Closed
Market Cap: 7.1m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

S2Medical AB (publ)
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

S2Medical AB (publ)
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
S
S2Medical AB (publ)
STO:S2M
Operating Income
kr2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Operating Income
-kr88.5m
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Operating Income
kr56.8m
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
20%
D
Doxa AB
STO:DOXA
Operating Income
-kr7.5m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
10%
Bactiguard Holding AB
STO:BACTI B
Operating Income
-kr118m
CAGR 3-Years
-128%
CAGR 5-Years
-76%
CAGR 10-Years
N/A
V
Vimian Group AB
STO:VIMIAN
Operating Income
€39.4m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

S2Medical AB (publ)
Glance View

Market Cap
7.1m SEK
Industry
Health Care

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

S2M Intrinsic Value
0.0322 SEK
Undervaluation 74%
Intrinsic Value
Price
S

See Also

What is S2Medical AB (publ)'s Operating Income?
Operating Income
2.2m SEK

Based on the financial report for Jun 30, 2024, S2Medical AB (publ)'s Operating Income amounts to 2.2m SEK.

Back to Top